AGREEMENT AND PLAN OF MERGER among CONCENTRA BIOSCIENCES, LLC, CONCENTRA MERGER SUB, INC. and JOUNCE THERAPEUTICS, INC. Dated as of March 26, 2023Agreement and Plan of Merger • March 27th, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2023 (this “Agreement”), is entered into by and between Concentra Biosciences, LLC, a Delaware limited liability company (the “Parent”), Concentra Merger Sub, Inc., a Delaware corporation and a wholly-owned Subsidiary of Parent (the “Purchaser”), [●], a [●], as Rights Agent (as defined herein), and [●], solely in its capacity as the initial representative, agent and attorney in-fact of the Holders (the “Representative”).
ContractJounce Therapeutics, Inc. • March 27th, 2023 • Biological products, (no disgnostic substances)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
